TVTX vs. CRAK

Last updated Jul 17, 2026

TVTX (Travere Therapeutics, Inc.) is a stock, while CRAK (VanEck Oil Refiners ETF) is Energy Equities fund tracking the MVIS Global Oil Refiners Index. Over the past 10 years, TVTX returned 12.13%/yr vs 14.30%/yr for CRAK. At a 0.21 correlation, their price movements are largely independent.

Performance

TVTX vs. CRAK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Travere Therapeutics, Inc. (TVTX) and VanEck Oil Refiners ETF (CRAK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with TVTX having a 44.67% return and CRAK slightly lower at 42.91%. Over the past 10 years, TVTX has underperformed CRAK with an annualized return of 12.13%, while CRAK has yielded a comparatively higher 14.30% annualized return.

TVTX

• 1D: -2.57%
• 1M: 3.56%
• 6M: 94.65%
• YTD: 44.67%
• 1Y: 231.81%
• 3Y*: 51.59%
• 5Y*: 32.03%
• 10Y*: 12.13%

CRAK

• 1D: 1.82%
• 1M: 14.02%
• 6M: 33.04%
• YTD: 42.91%
• 1Y: 62.07%
• 3Y*: 24.13%
• 5Y*: 18.22%
• 10Y*: 14.30%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TVTX vs. CRAK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TVTX Travere Therapeutics, Inc.	44.67%	119.35%	93.77%	-57.25%	-32.25%	13.89%	91.94%	-37.25%	7.40%	11.30%
CRAK VanEck Oil Refiners ETF	42.91%	39.11%	-15.05%	13.73%	19.10%	10.90%	-11.22%	9.15%	-10.46%	49.86%

Correlation

The correlation between TVTX and CRAK is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since Aug 19, 2015	0.22

The correlation between TVTX and CRAK shifts across timeframes, from -0.01 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.

Return for Risk

TVTX vs. CRAK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TVTX

TVTX Risk / Return Rank: 97
TVTX Sharpe Ratio Rank: 98
TVTX Sortino Ratio Rank: 97
TVTX Omega Ratio Rank: 96
TVTX Calmar Ratio Rank: 97
TVTX Martin Ratio Rank: 96

CRAK

CRAK Risk / Return Rank: 93
CRAK Sharpe Ratio Rank: 96
CRAK Sortino Ratio Rank: 94
CRAK Omega Ratio Rank: 93
CRAK Calmar Ratio Rank: 91
CRAK Martin Ratio Rank: 88

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TVTX vs. CRAK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and VanEck Oil Refiners ETF (CRAK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TVTX	CRAK	Difference
Sharpe ratio: Return per unit of total volatility	3.28	3.18	+0.10
Sortino ratio: Return per unit of downside risk	4.12	4.10	+0.02
Omega ratio: Gain probability vs. loss probability	1.52	1.52	0.00
Calmar ratio: Return relative to maximum drawdown	6.97	4.59	+2.38
Martin ratio: Return relative to average drawdown	16.16	14.95	+1.21

TVTX vs. CRAK - Sharpe Ratio Comparison

The current TVTX Sharpe Ratio is 3.28, which is comparable to the CRAK Sharpe Ratio of 3.18. The chart below compares the historical Sharpe Ratios of TVTX and CRAK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TVTX vs. CRAK - Drawdown Comparison

The maximum TVTX drawdown since its inception was -85.43%, which is greater than CRAK's maximum drawdown of -58.80%. Use the drawdown chart below to compare losses from any high point for TVTX and CRAK.

Drawdown Indicators

	TVTX	CRAK	Difference
Max Drawdown Largest peak-to-trough decline	-85.43%	-58.80%	-26.63%
Max Drawdown (1Y) Largest decline over 1 year	-33.49%	-13.59%	-19.90%
Max Drawdown (3Y) Largest decline over 3 years	-69.51%	-35.61%	-33.90%
Max Drawdown (5Y) Largest decline over 5 years	-83.12%	-35.61%	-47.51%
Max Drawdown (10Y) Largest decline over 10 years	-83.64%	-58.80%	-24.84%
Current Drawdown Current decline from peak	-6.35%	0.00%	-6.35%
Average Drawdown Average peak-to-trough decline	-40.82%	-12.44%	-28.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.43%	4.16%	+10.27%

Volatility

TVTX vs. CRAK - Volatility Comparison

Travere Therapeutics, Inc. (TVTX) has a higher volatility of 7.54% compared to VanEck Oil Refiners ETF (CRAK) at 6.58%. This indicates that TVTX's price experiences larger fluctuations and is considered to be riskier than CRAK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TVTX	CRAK	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.54%	6.58%	+0.96%
Volatility (6M) Calculated over the trailing 6-month period	46.91%	15.65%	+31.26%
Volatility (1Y) Calculated over the trailing 1-year period	71.11%	19.65%	+51.46%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	66.33%	20.74%	+45.59%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	58.35%	22.19%	+36.16%

Dividends

TVTX vs. CRAK - Dividend Comparison

TVTX has not paid dividends to shareholders, while CRAK's dividend yield for the trailing twelve months is around 1.41%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRAK VanEck Oil Refiners ETF	1.41%	2.02%	5.60%	3.65%	3.08%	2.40%	2.64%	1.49%	2.42%	1.66%	3.42%	0.47%
TVTX Travere Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both TVTX and CRAK in my portfolio?

TVTX and CRAK have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TVTX or CRAK?

TVTX has higher volatility (7.54%) compared to CRAK (6.58%). In terms of maximum drawdown, TVTX dropped -85.43% vs CRAK's -58.80%.

Which has better risk-adjusted returns?

TVTX currently has the higher Sharpe Ratio (3.28 vs 3.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.